市場調査レポート
商品コード
1065551

デジタルバイオマーカーの世界市場

Digital Biomarkers: Global Markets

出版日: | 発行: BCC Research | ページ情報: 英文 103 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
デジタルバイオマーカーの世界市場
出版日: 2022年03月15日
発行: BCC Research
ページ情報: 英文 103 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のデジタルバイオマーカーの世界市場は、2021年の18億米ドルから、2026年には72億米ドルに成長すると予測されています。

また、2021年から2026年のCAGRは31.6%となる見込みです。

当レポートでは、世界のデジタルバイオマーカー市場について分析し、技術の概要や市場の基本構造、主な市場促進・抑制要因、市場規模・成長率・市場シェアの動向見通し (2019年~2026年)、地域別・システムコンポーネント別・用途別・治療領域別・エンドユーザー別・地域別の詳細動向、主要企業のプロファイル、市場競争・事業展開の動き、新型コロナウイルス感染症 (COVID-19) による影響、といった情報を取りまとめてお届けいたします。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 デジタルバイオマーカー:背景と技術

  • デジタルバイオマーカーの概要

第4章 市場力学

  • 市場力学
  • 市場の促進要因
  • 市場の抑制要因
  • 市場機会

第5章 システムコンポーネント別の市場区分

  • 世界のデジタルバイオマーカー市場
  • 市場分析
  • データ収集ツール
  • データ統合ツール

第6章 用途別の市場区分

  • 診断用デジタルバイオマーカー
  • 監視用デジタルバイオマーカー
  • 予測用デジタルバイオマーカー
  • その他のデジタルバイオマーカー

第7章 治療領域別の市場区分

  • 世界のデジタルバイオマーカー市場:治療領域別
  • CVMD
  • 精神障害
  • 神経症
  • 呼吸器疾患
  • 筋骨格障害
  • その他の治療領域

第8章 エンドユーザー別の市場区分

  • 世界のデジタルバイオマーカー市場:エンドユーザー別
  • 製薬企業・研究機関
  • 医療提供者
  • 支払者
  • 雇用主
  • 患者・介護者

第9章 地域別の市場区分

  • 世界のデジタルバイオマーカー市場:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 規制シナリオ

  • 米国
  • カナダ
  • 欧州
  • アジア太平洋

第11章 COVID-19パンデミックの影響

  • COVID-19のデジタルバイオマーカー市場への影響

第12章 競合情勢

  • 概要
  • 製薬企業
  • 大手のテクノロジー企業
  • 中小のテクノロジー企業
  • 主要企業の最新動向
  • その他の注目すべきパートナーシップと資金調達活動

第13章 企業プロファイル

  • ACTIGRAPH LLC
  • ALIVECOR INC.
  • AKILI INTERACTIVE LABS INC.
  • BIOGEN INC.
  • EMBIC CORP.
  • EVIDATION HEALTH INC.
  • FITBIT LLC
  • HAPPIFY HEALTH
  • HUMA
  • IXICO PLC
  • KONEKSA
  • MINDSTRONG HEALTH
  • WINTERLIGHT LABS

第14章 付録:頭字語のリスト

図表

List of Tables

  • Summary Table : Global Market for Digital Biomarkers, by System Component, Through 2026
  • Table 1 : Types of Digital Biomarkers
  • Table 2 : Comparison of Traditional and Digital Biomarkers
  • Table 3 : Digital Health Apps Globally, 2015-2021
  • Table 4 : Technology Innovations by Digital Biomarker Companies
  • Table 5 : Key Research Collaborations and Partnerships
  • Table 6 : Global Market for Digital Biomarkers, by System Component, Through 2026
  • Table 7 : Global Market for Data Collection Tools, by Region, Through 2026
  • Table 8 : Global Market for Data Collection Tools, by Type, Through 2026
  • Table 9 : Global Market for Mobile and Web Apps as Data Collection Tools, Through 2026
  • Table 10 : Global Market for Wearable Data Collection Tools, by Region, Through 2026
  • Table 11 : Global Market for Implantable and Ingestible Data Collection Tools, by Region, Through 2026
  • Table 12 : Global Market for Other Data Collection Tools, by Region, Through 2026
  • Table 13 : Global Market for Data Integration Tools, by Region, Through 2026
  • Table 14 : Global Market for Digital Biomarkers, by Application, Through 2026
  • Table 15 : Global Market for Diagnostic Digital Biomarkers, by Region, Through 2026
  • Table 16 : Global Market for Monitoring Digital Biomarkers, by Region, Through 2026
  • Table 17 : Global Market for Predictive Digital Biomarkers, by Region, Through 2026
  • Table 18 : Global Market for Other Digital Biomarkers, by Region, Through 2026
  • Table 19 : Global Market for Digital Biomarkers, by Therapeutic Area, Through 2026
  • Table 20 : Global Market for Digital Biomarkers for CVMD, by Region, Through 2026
  • Table 21 : Global Market for Digital Biomarkers for Psychiatric Disorders, by Region, Through 2026
  • Table 22 : Global Market for Digital Biomarkers for Neurology, by Region, Through 2026
  • Table 23 : Global Market for Digital Biomarkers for Respiratory Disorders, by Region, Through 2026
  • Table 24 : Global Market for Digital Biomarkers for Musculoskeletal, by Region, Through 2026
  • Table 25 : Global Market for Digital Biomarkers for Other Therapeutic Areas, by Region, Through 2026
  • Table 26 : Global Market for Digital Biomarkers, by End User, Through 2026
  • Table 27 : Global Market for Digital Biomarkers, by Region, Through 2026
  • Table 28 : North American Market for Digital Biomarkers, by Country, Through 2026
  • Table 29 : European Market for Digital Biomarkers, by Country, Through 2026
  • Table 30 : Asia-Pacific Market for Digital Biomarkers, by Country, Through 2026
  • Table 31 : Collaborations Between Pharmaceutical and Digital Biomarker Companies, 2021-2022
  • Table 32 : Actigraph LLC: Product Portfolio
  • Table 33 : Actigraph LLC: Key Developments
  • Table 34 : AliveCor: Product Portfolio
  • Table 35 : AliveCor: Key Developments
  • Table 36 : Akili Interactive Labs: Product Portfolio
  • Table 37 : Akili Interactive Labs: Key Developments
  • Table 38 : Biogen Product Portfolio
  • Table 39 : Embic: Product Portfolio
  • Table 40 : Evidation Health: Product Portfolio
  • Table 41 : Evidation Health: Key Developments
  • Table 42 : Fitbit: Product Portfolio
  • Table 43 : Fitbit: Key Developments
  • Table 44 : Happify Health: Product Portfolio
  • Table 45 : Happify Health: Key Developments
  • Table 46 : Huma: Product Portfolio
  • Table 47 : Ixico: Product Portfolio
  • Table 48 : Ixico: Key Developments
  • Table 49 : Koneksa Product Portfolio
  • Table 50 : Koneska: Key Developments
  • Table 51 : Mindstrong Health: Product Portfolio
  • Table 52 : Mindstrong Health: Key Developments
  • Table 53 : Winterlight Labs: Product Portfolio
  • Table 54 : Winterlight Labs: Key Developments
  • Table 55 : Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market for Digital Biomarkers, by System Component, 2019-2026
  • Figure 1 : Distribution of Clinical Trials with Digital Biomarkers as Endpoints by Therapeutic Area
  • Figure 2 : Global Shares of Digital Biomarker System Components, 2020
  • Figure 3 : Global Market for Data Collection Tools, by Region, 2019-2026
  • Figure 4 : Global Market Shares of Digital Biomarker Data Collection Tools, 2020
  • Figure 5 : Global Market for Data Integration Tools, by Region, 2019-2026
  • Figure 6 : Global Market Shares of Digital Biomarkers, by Application, 2020
  • Figure 7 : Global Market for Diagnostic Digital Biomarkers, 2019-2026
  • Figure 8 : Global Market for Monitoring Digital Biomarkers, 2019-2026
  • Figure 9 : Global Market for Predictive Digital Biomarkers, 2019-2026
  • Figure 10 : Global Market for Other Digital Biomarkers, 2019-2026
  • Figure 11 : Global Market Shares of Digital Biomarkers, by Therapeutic Area, 2020
  • Figure 12 : Global Market Shares of Digital Biomarkers, by End User, 2020
  • Figure 13 : Global Market for Digital Biomarkers, by End User, 2019-2026
  • Figure 14 : Global Market for Digital Biomarkers Used by Pharmaceutical Companies and Research Institutions, 2019-2026
  • Figure 15 : Global Market for Digital Biomarkers Used by Healthcare Providers, 2019-2026
  • Figure 16 : Global Market for Digital Biomarkers Used by Payers, 2019-2026
  • Figure 17 : Global Market for Digital Biomarkers Used by Employers, 2019-2026
  • Figure 18 : Global Market for Digital Biomarkers Used by Patients and Caregivers, 2019-2026
  • Figure 19 : Global Market Shares of Digital Biomarkers, by Region, 2020
  • Figure 20 : North American Market Shares of Digital Biomarkers, by Country, 2020
  • Figure 21 : U.S. Market for Digital Biomarkers, 2019-2026
  • Figure 22 : Canadian Market for Digital Biomarkers, 2019-2026
  • Figure 23 : Mexican Market for Digital Biomarkers, 2019-2026
  • Figure 24 : European Market Shares of Digital Biomarkers, by Country, 2020
  • Figure 25 : German Market for Digital Biomarkers, 2019-2026
  • Figure 26 : U.K. Market for Digital Biomarkers, 2019-2026
  • Figure 27 : Belgian Market for Digital Biomarkers, 2019-2026
  • Figure 28 : Rest of Europe Market for Digital Biomarkers, 2019-2026
  • Figure 29 : Asia-Pacific Market Shares of Digital Biomarkers, by Country, 2020
  • Figure 30 : Chinese Market for Digital Biomarkers, 2019-2026
  • Figure 31 : Australian Market for Digital Biomarkers, 2019-2026
  • Figure 32 : Japanese Market for Digital Biomarkers, 2019-2026
  • Figure 33 : Rest of Asia-Pacific Market for Digital Biomarkers, 2019-2026
  • Figure 34 : RoW Market for Digital Biomarkers, 2019-2026
  • Figure 35 : Digital Biomarkers: Competitor Types and Their Strategies
  • Figure 36 : Biogen: Annual Revenue, 2018-2020
  • Figure 37 : Biogen: Revenue Share, by Region, 2020
  • Figure 38 : Fitbit: Annual Revenue, 2019 and 2020
  • Figure 39 : Ixico: Annual Revenue, 2019 and 2020
目次
Product Code: BIO227A

Highlights:

The global market for digital biomarkers should grow from $1.8 billion in 2021 to $7.2 billion by 2026, at compound annual growth rate (CAGR) of 31.6% for the period of 2021-2026.

Data collection tools market should grow from $1.2 billion in 2021 to $4.4 billion by 2026, at a CAGR of 30.0% for the period of 2021-2026.

Data integration systems market should grow from $635.7 million in 2021 to $2.8 billion by 2026, at a CAGR of 34.4% for the period of 2021-2026.

Report Scope:

The current report highlights the current and future market potential of digital biomarkers and also covers market projections to 2026, along with rankings for key market players. It also analyzes the competitive landscape and the regulatory scenario. The report determines the market share of digital biomarkers based on system components, application, therapeutic area and end user. The market by system component is segmented into data collection tools and data integration tools; by application, it is segmented into diagnostic digital biomarkers, monitoring digital biomarkers, predictive digital biomarkers and others; by therapeutic area, it is categorized into cardiovascular and metabolic disorders (CVMD), psychiatric disorders, neurological disorders, respiratory disorders, musculoskeletal disorders and others; and by end user, it is segmented into pharmaceutical companies and research institutions, healthcare providers, payers, employers, patients and caregivers. The report also assesses the impact of the COVID-19 pandemic on this market.

By geography, the market has been segmented into North America, Europe, Asia-Pacific and the rest of the world (RoW). North America consists of the U.S., Canada and Mexico; Europe includes Germany, the U.K., Belgium and Rest of Europe; and Asia-Pacific includes China, Australia, Japan and Rest of Asia-Pacific. For market estimates, data has been provided for the 2019 as the historic year, 2020 as the base year and forecast for 2026.

Report Includes:

  • 56 tables
  • An overview of the global markets for digital biomarkers
  • Estimation of the market size and analyses of market trends, with data from 2019, 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
  • Information on major market drivers, opportunities and challenges, industry chain structure, distribution channel, and technological advancements that are affecting the overall marketplace
  • Assessment of market potential and revenue forecast for digital biomarkers market based on system component, application, therapeutic area, end user and region
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Company profiles of the leading market players including AliveCor, Biogen Inc., Embic Corp., Fitbit, Happify Health, Mindstrong Health, and Winterlight Labs

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of this Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Market Highlights

Chapter 3 Digital Biomarkers: Background and Technology

  • Digital Biomarkers Overview

Chapter 4 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities

Chapter 5 Market Breakdown by System Component

  • Global Market for Digital Biomarkers
  • Market Analysis
  • Data Collection Tools
  • Data Integration Tools

Chapter 6 Market Breakdown by Application

  • Diagnostic Digital Biomarkers
  • Monitoring Digital Biomarkers
  • Predictive Digital Biomarkers
  • Other Digital Biomarkers

Chapter 7 Market Breakdown by Therapeutic Area

  • Global Market for Digital Biomarkers by Therapeutic Area
  • CVMD
  • Psychiatric Disorders
  • Neurology
  • Respiratory Disorders
  • Musculoskeletal
  • Other Therapeutic Areas

Chapter 8 Market Breakdown by End User

  • Global Market for Digital Biomarkers by End User
  • Pharmaceutical Companies and Research Institutions
  • Healthcare Providers
  • Payers
  • Employers
  • Patients and Caregivers

Chapter 9 Market Breakdown by Region

  • Global Market for Digital Biomarkers by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 10 Regulatory Scenario

  • U.S.
  • Canada
  • Europe
  • Asia-Pacific

Chapter 11 Impact of the COVID-19 Pandemic

  • COVID-19's Impact on the Digital Biomarker Market

Chapter 12 Competitive Landscape

  • Overview
  • Pharmaceutical Companies
  • Large Technology Companies
  • Small-Medium Sized Technology Companies
  • Recent Developments of Key Companies
  • Other Notable Partnerships and Funding Activities

Chapter 13 Company Profiles

  • ACTIGRAPH LLC
  • ALIVECOR INC.
  • AKILI INTERACTIVE LABS INC.
  • BIOGEN INC.
  • EMBIC CORP.
  • EVIDATION HEALTH INC.
  • FITBIT LLC
  • HAPPIFY HEALTH
  • HUMA
  • IXICO PLC
  • KONEKSA
  • MINDSTRONG HEALTH
  • WINTERLIGHT LABS

Chapter 14 Appendix: List of Acronyms